MYC and neoplasm: reported that, in MYC‐driven tumours, inhibition of topoisomerase I (TOP1) promotes aberrant R‐loop accumulation, markedly exacerbates pre‐existing transcription–replication conflicts and DNA damage, and thereby induces a MYC‐selective synthetic lethal effect.